121 related articles for article (PubMed ID: 37268061)
21. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
22. Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway.
Yang Q; Xie B; Tang H; Meng W; Jia C; Zhang X; Zhang Y; Zhang J; Li H; Fu B
J Exp Clin Cancer Res; 2019 Jun; 38(1):263. PubMed ID: 31208444
[TBL] [Abstract][Full Text] [Related]
23. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
24. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway.
Mei J; Lin W; Li S; Tang Y; Ye Z; Lu L; Wen Y; Kan A; Zou J; Yu C; Wei W; Guo R
J Exp Clin Cancer Res; 2022 Jan; 41(1):5. PubMed ID: 34980201
[TBL] [Abstract][Full Text] [Related]
26. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.
Geng X; Geng Z; Li H; Zhang Y; Li J; Chang H
Liver Int; 2020 Jul; 40(7):1756-1769. PubMed ID: 32174027
[TBL] [Abstract][Full Text] [Related]
28. PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB.
Zeng T; Tang Z; Liang L; Suo D; Li L; Li J; Yuan Y; Guan XY; Li Y
Mol Oncol; 2020 Dec; 14(12):3184-3197. PubMed ID: 33064899
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression.
Li J; Lau G; Chen L; Yuan YF; Huang J; Luk JM; Xie D; Guan XY
PLoS One; 2012; 7(9):e46264. PubMed ID: 23050001
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
32. HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway.
Li M; Tan T; Geng Y; Tao Y; Pan J; Zhang J; Xu Q; Shen H; Zuo L; Chen Y
Ann Hepatol; 2023; 28(1):100759. PubMed ID: 36179794
[TBL] [Abstract][Full Text] [Related]
33. Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Wang F; Yang JL; Yu KK; Xu M; Xu YZ; Chen L; Lu YM; Fang HS; Wang XY; Hu ZQ; Li FF; Kan L; Luo J; Wang SY
Mol Cancer; 2015 Jan; 14(1):10. PubMed ID: 25622857
[TBL] [Abstract][Full Text] [Related]
34. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
36. SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Lu P; Ding Q; Li X; Ji X; Li L; Fan Y; Xia Y; Tian D; Liu M
EBioMedicine; 2019 Oct; 48():100-116. PubMed ID: 31597595
[TBL] [Abstract][Full Text] [Related]
37. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
Dai T; Zhang D; Cai M; Wang C; Wu Z; Ying Z; Wu J; Li M; Xie D; Li J; Song L
J Pathol; 2015 Feb; 235(3):490-501. PubMed ID: 25385148
[TBL] [Abstract][Full Text] [Related]
38. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
39. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
40. Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway.
Lin JP; Huang MH; Sun ZT; Chen L; Lei YH; Huang YQ; Qi M; Fan SR; Chen SG; Chung CW; Chan MC; Liu JS; Hu M; Chen MF; Ye WC; Chen YY; Deng LJ
Life Sci; 2023 Jul; 324():121715. PubMed ID: 37100377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]